Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

James A. Jorgenson, MS, RPh, FASHP

Articles by James A. Jorgenson, MS, RPh, FASHP

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion

ByBenjamin Rix Brooks, MD,James A. Jorgenson, MS, RPh, FASHP,Barbara J. Newhouse, MS, BSW,Jeremy M. Shefner, MD, PhD,Wendy Agnese, PharmD

April 24th 2018

Edaravone in the Treatment of Amyotrophic Lateral Sclerosis: Efficacy and Access to Therapy - A Roundtable Discussion Appendix

ByBenjamin Rix Brooks, MD,James A. Jorgenson, MS, RPh, FASHP,Barbara J. Newhouse, MS, BSW,Jeremy M. Shefner, MD, PhD,Wendy Agnese, PharmD

April 24th 2018

Latest Updated Articles

Trending on AJMC

FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer

CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes

More Potent and Tolerable, Azenosertib Advances as the Leading WEE1 Inhibitor

Clinicians Confront Fragmented Care and the Silent Burden of Undertreated Atopic Dermatitis

Health Care Spending to Hit $9 Trillion by 2034, According to New Analysis